Harpoon Stock Analysis

HARP -  USA Stock  

USD 9.82  0.02  0.20%

The small decline in market price for the last few months may raise some interest from insiders. The stock closed today at a share price of 9.82 on 143,053 in trading volume. The company directors and management did not add much value to Harpoon Therapeutics investors in July. However, diversifying your holdings with Harpoon Therapeutics or similar stocks can still protect your portfolio during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.94. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Harpoon Therapeutics partners.
Please check Risk vs Return Analysis.

Search Stock Analysis 

The Harpoon Therapeutics stock analysis report makes it easy to digest most publicly released information about Harpoon Therapeutics and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Harpoon Stock analysis module also helps to analyze the Harpoon Therapeutics price relationship with some important fundamental indicators such as market cap and management efficiency.

Harpoon Stock Analysis Notes

About 81.0% of the company shares are owned by institutional investors. The book value of Harpoon Therapeutics was currently reported as 3.16. The company recorded a loss per share of 3.71. Harpoon Therapeutics had not issued any dividends in recent years. Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the bodys immune system to treat patients suffering from cancer and other diseases in the United States. Harpoon Therapeutics, Inc. was founded in 2015 and is headquartered in South San Francisco, California. Harpoon Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 84 people. To learn more about Harpoon Therapeutics call Gerald McMahon at 650 443 7400 or check out http://www.harpoontx.com.

Harpoon Therapeutics Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Harpoon Therapeutics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Harpoon Therapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Harpoon Therapeutics generates negative expected return over the last 90 days
Harpoon Therapeutics has high historical volatility and very poor performance
Harpoon Therapeutics is unlikely to experience financial distress in the next 2 years
The company reported the previous year's revenue of 23.15 M. Net Loss for the year was (99.08 M) with loss before overhead, payroll, taxes, and interest of (35.12 M).
Harpoon Therapeutics currently holds about 229.41 M in cash with (9.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.05.
Harpoon Therapeutics has a frail financial position based on the latest SEC disclosures
Over 81.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: Were Hedge Funds Right About Harpoon Therapeutics, Inc. - Yahoo Finance

Harpoon Therapeutics Upcoming and Recent Events

Earnings reports are used by Harpoon Therapeutics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Harpoon Therapeutics previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report4th of August 2021
Next Earnings Report3rd of November 2021
Next Fiscal Quarter End30th of June 2021
Next Fiscal Year End9th of March 2022
Last Quarter Report31st of March 2021
Last Earning Announcement30th of June 2020

Harpoon Largest EPS Surprises

Earnings surprises can significantly impact Harpoon Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Harpoon Therapeutics SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Harpoon Therapeutics prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Harpoon Therapeutics investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Harpoon Therapeutics specific information freely available to individual and institutional investors to make a timely investment decision.
15th of July 2021
Unclassified Corporate Event
4th of June 2021
Financial Statements and Exhibits. Other Events
6th of May 2021
Unclassified Corporate Event. Unclassified Corporate Event. Unclassified Corporate Event. Unclassified Corporate Event. Completion of Acquisition or Disposition of Assets
26th of April 2021
Other Events
24th of March 2021
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
10th of March 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
16th of February 2021
Unclassified Corporate Event
12th of February 2021
Unclassified Corporate Event

Harpoon Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 318.41 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Harpoon Therapeutics's market, we take the total number of its shares issued and multiply it by Harpoon Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Harpoon Profitablity

Harpoon Therapeutics' profitability indicators refer to fundamental financial ratios that showcase Harpoon Therapeutics' ability to generate income relative to its revenue or operating costs. If, let's say, Harpoon Therapeutics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Harpoon Therapeutics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Harpoon Therapeutics' profitability requires more research than a typical breakdown of Harpoon Therapeutics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2021
Return on Average Assets(0.28) (0.30) 
Return on Average Equity(0.74) (0.76) 
Return on Invested Capital(0.40) (0.43) 
Return on Sales(2.86) (3.08) 

Management Efficiency

The entity has return on total asset (ROA) of (14.75) % which means that it has lost $14.75 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (106.73) %, meaning that it created substantial loss on money invested by shareholders. Harpoon Therapeutics management efficiency ratios could be used to measure how well harpoon therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of 5th of August 2021, Return on Average Assets is likely to drop to -0.3. In addition to that, Return on Average Equity is likely to drop to -0.76. As of 5th of August 2021, Total Liabilities is likely to grow to about 127 M. Also, Current Liabilities is likely to grow to about 51.7 M
Last ReportedProjected for 2021
Book Value per Share 2.15  2.32 
Enterprise Value over EBIT(8.00) (8.63) 
Enterprise Value over EBITDA(8.71) (9.40) 
Price to Book Value 7.83  7.51 
Tangible Assets Book Value per Share 6.85  7.03 
Enterprise Value413 M430.3 M
Tangible Asset Value171.6 M147.2 M

Technical Drivers

As of the 5th of August, Harpoon Therapeutics retains the risk adjusted performance of 4.0E-4, and Market Risk Adjusted Performance of (0.07). Harpoon Therapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Harpoon Therapeutics, which can be compared to its competitors. Please check out Harpoon Therapeutics variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Harpoon Therapeutics is priced fairly, providing market reflects its last-minute price of 9.82 per share. Given that Harpoon Therapeutics has jensen alpha of (0.12), we strongly advise you to confirm Harpoon Therapeutics's regular market performance to make sure the company can sustain itself at a future point.

Harpoon Therapeutics Price Movement Analysis

The output start index for this execution was twenty-nine with a total number of output elements of two hundred thirty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Harpoon Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Harpoon Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.

Harpoon Therapeutics Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Harpoon Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Harpoon Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Harpoon Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Harpoon Therapeutics Predictive Daily Indicators

Harpoon Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Harpoon Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Harpoon Therapeutics Forecast Models

Harpoon Therapeutics time-series forecasting models is one of many Harpoon Therapeutics' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Harpoon Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Harpoon Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Harpoon Therapeutics stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Harpoon shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Harpoon Therapeutics. By using and applying Harpoon Stock analysis, traders can create a robust methodology for identifying Harpoon entry and exit points for their positions.
Last ReportedProjected for 2021
EBITDA Margin(2.72) (2.93) 
Gross Margin 0.90  0.89 
Profit Margin(2.86) (3.08) 
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the bodys immune system to treat patients suffering from cancer and other diseases in the United States. Harpoon Therapeutics, Inc. was founded in 2015 and is headquartered in South San Francisco, California. Harpoon Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 84 people.

Current Harpoon Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Harpoon analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Harpoon analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Harpoon Therapeutics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Harpoon analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Harpoon stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Harpoon Therapeutics, talking to its executives and customers, or listening to Harpoon conference calls.
Harpoon Analyst Advice Details

Harpoon Stock Analysis Indicators

Harpoon Therapeutics stock analysis indicators help investors evaluate how Harpoon Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Harpoon Therapeutics shares will generate the highest return on investment. By understating and applying Harpoon Therapeutics stock analysis, traders can identify Harpoon Therapeutics position entry and exit signals to maximize returns.
Quick Ratio2.34
Fifty Two Week Low9.79
Revenue Growth173.20%
Shares Short Prior Month932.81k
Average Daily Volume Last 10 Day1.07M
Average Daily Volume In Three Month439.31k
Shares Percent Shares Out3.57%
Gross Margins-142.99%
Short Percent Of Float3.82%
Forward Price Earnings-4.75
Float Shares18.1M
Fifty Two Week High25.24
Enterprise Value To Ebitda-5.42
Fifty Day Average13.41
Two Hundred Day Average18.50
Enterprise Value To Revenue11.20
Please check Risk vs Return Analysis. Note that the Harpoon Therapeutics information on this page should be used as a complementary analysis to other Harpoon Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Harpoon Stock analysis

When running Harpoon Therapeutics price analysis, check to measure Harpoon Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harpoon Therapeutics is operating at the current time. Most of Harpoon Therapeutics' value examination focuses on studying past and present price action to predict the probability of Harpoon Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Harpoon Therapeutics' price. Additionally, you may evaluate how the addition of Harpoon Therapeutics to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Global Correlations
Find global opportunities by holding instruments from different markets
The market value of Harpoon Therapeutics is measured differently than its book value, which is the value of Harpoon that is recorded on the company's balance sheet. Investors also form their own opinion of Harpoon Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Harpoon Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harpoon Therapeutics' market value can be influenced by many factors that don't directly affect Harpoon Therapeutics underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harpoon Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Harpoon Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harpoon Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.